Key result
Amlodipine/benazepril 10/40 and 10//day reduced sitting BP by 13.3/12.7 and 12.1/11.6 mmHg, respectively, compared with 6.6/8.5 mmHg for amlodipine monotherapy.
Why the study?
Does amlodipine/benazepril combination therapy improve blood pressure reduction in patients not adequately controlled with amlodipine monotherapy?
RCT (n=812)
randomized
Does amlodipine/benazepril combination therapy improve blood pressure reduction in patients not adequately controlled with amlodipine monotherapy?
Amlodipine/benazepril combination therapy provides superior blood pressure reduction and higher responder rates compared to amlodipine monotherapy in patients with inadequately controlled hypertension.
Answers are grounded in this paper and cite their sources.
Favors amlodipine/benazepril over monotherapy for greater BP reduction; extends evidence for dual therapy in amlodipine-uncontrolled hypertension.
BACKGROUND: This study compared the efficacy and safety of amlodipine/benazepril (10/40 mg/day and 10/20 mg/day) with amlodipine 10 mg/day in patients whose blood pressure (BP) was not adequately controlled with amlodipine monotherapy. METHODS: After a lead-in period with amlodipine monotherapy, 812 non-responder patients (mean sitting diastolic BP > or =95 mmHg) were randomized to one of three treatment groups. Ambulatory BP monitoring was conducted in 276 patients. RESULTS: Treatment with amlodipine/benazepril 10/40 mg/day and 10/20 mg/day resulted in a decrease of mean sitting systolic and mean sitting diastolic BP by 13.3/12.7 mmHg and 12.1/11.6 mmHg, respectively, compared with monotherapy (6.6/8.5 mmHg) (p < 0.0001). Both combinations resulted in more responders than monotherapy (74% and 65% vs. 54%; p < 0.0001 and p < 0.0085, respectively). Amlodipine/benazepril 10/40 mg/day and 10/20 mg/day decreased ambulatory systolic and diastolic BP by 9.9/6.7 mmHg and 7.4/5.2 mmHg compared with monotherapy (p < 0.0001). The incidence of pedal edema was lower in the amlodipine/benazepril combinations compared with monotherapy (4.5%, 5.5% vs. 9.2%, respectively, p=NS). No significant metabolic side-effects were noted among the combination groups. CONCLUSION: Amlodipine/benazepril combinations were well tolerated and resulted in significant BP reductions and better BP responder rates than amlodipine monotherapy.
No takes yet. Share an insight, caveat, or question.
Chrysant et al. (2007) conducted an RCT in blood pressure not adequately controlled with amlodipine monotherapy (n=812). amlodipine/benazepril vs. amlodipine 10 mg/day was evaluated on decrease of mean sitting systolic and mean sitting diastolic BP (p=< 0.0001). Amlodipine/benazepril 10/40 and 10//day reduced sitting BP by 13.3/12.7 and 12.1/11.6 mmHg, respectively, compared with 6.6/8.5 mmHg for amlodipine monotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: